We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$6.67B
AUM Growth
+$1.19B
Cap. Flow
+$920M
Cap. Flow %
13.78%
Top 10 Hldgs %
8.71%
Holding
4,737
New
1,614
Increased
1,035
Reduced
726
Closed
872

Sector Composition

Rank Sector Weight
1 Financials 10.09%
2 Technology 9.35%
3 Consumer Discretionary 8.74%
4 Industrials 8.22%
5 Healthcare 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
2551
PUT
RTX Corp
RTX
$290B
$166K ﹤0.01%
+1,700
New +$167K
SLGN icon
2552
PUT
Silgan Holdings
SLGN
$4.23B
$166K ﹤0.01%
+3,100
New +$163K
AMN icon
2553
PUT
AMN Healthcare
AMN
$1.3B
$166K ﹤0.01%
2,000
+1,800
+900% +$169K
ISEE
2554
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$165K ﹤0.01%
+6,800
New +$149K
GRDI
2555
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$165K ﹤0.01%
16,000
PGSS.U
2556
DELISTED
Pegasus Digital Mobility Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
PGSS.U
$165K ﹤0.01%
15,791
UHS icon
2557
PUT
Universal Health Services
UHS
$10.2B
$165K ﹤0.01%
+1,300
New +$179K
PPLI
2558
People Inc
PPLI
$3.09B
$165K ﹤0.01%
+3,903
New +$167K
ALOR
2559
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$165K ﹤0.01%
+16,000
New +$165K
PLRX icon
2560
CALL
Pliant Therapeutics
PLRX
$64.4M
$165K ﹤0.01%
+6,200
New +$177K
WING icon
2561
Wingstop
WING
$3.53B
$164K ﹤0.01%
+896
New +$147K
MIN
2562
Aberdeen Intermediate Income Fund
MIN
$274M
$164K ﹤0.01%
59,375
+41,633
+235% +$118K
REGN icon
2563
Regeneron Pharmaceuticals
REGN
$78.5B
$164K ﹤0.01%
+200
New +$151K
RUTH
2564
CALL
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$164K ﹤0.01%
+10,000
New +$174K
RMBS icon
2565
PUT
Rambus
RMBS
$9.87B
$164K ﹤0.01%
+3,200
New +$137K
CIVI
2566
CALL
DELISTED
Civitas Resources
CIVI
$164K ﹤0.01%
+2,400
New +$156K
EDIT icon
2567
CALL
Editas Medicine
EDIT
$396M
$164K ﹤0.01%
22,600
+2,100
+10% +$18.7K
HZNP
2568
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$164K ﹤0.01%
1,500
NVAX icon
2569
CALL
Novavax
NVAX
$1.2B
$164K ﹤0.01%
23,600
+2,200
+10% +$20.2K
GLNG icon
2570
Golar LNG
GLNG
$5B
$163K ﹤0.01%
7,567
-639
-8% -$14.3K
SAIA icon
2571
CALL
Saia
SAIA
$9.27B
$163K ﹤0.01%
+600
New +$160K
OPTX icon
2572
Syntec Optics
OPTX
$263M
$163K ﹤0.01%
16,000
BASE
2573
DELISTED
Couchbase
BASE
$163K ﹤0.01%
+11,563
New +$171K
AEON icon
2574
AEON Biopharma
AEON
$12.9M
$162K ﹤0.01%
+222
New +$161K
BG icon
2575
PUT
Bunge Global
BG
$20.4B
$162K ﹤0.01%
1,700
-12,300
-88% -$1.2M

Similar funds

Walleye Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Walleye Capital held 4,737 positions worth $6.67B, up 22% from $5.48B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Walleye Capital deployed $920M of net new capital in Q1 2023, opening 1,614 new positions and adding to 1,035 existing holdings. Its largest new stake was State Street SPDR S&P Regional Banking ETF: 628,376 shares worth $27.6M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Johnson Controls International, an estimated $23.1M trimmed.

  • Walleye Capital's largest Q1 2023 buy was State Street SPDR S&P Regional Banking ETF: 628,376 shares worth $27.6M.
  • Walleye Capital added most to American Homes 4 Rent in Q1 2023, an estimated $24M increase.
  • Walleye Capital's biggest Q1 2023 reduction was Johnson Controls International, cutting an estimated $23.1M.
  • Walleye Capital fully exited State Street SPDR S&P 500 ETF Trust in Q1 2023, selling an estimated $121M.
  • Walleye Capital's ten largest holdings make up 8.7% of its $6.67B portfolio in Q1 2023.
  • Walleye Capital opened 1,614 new positions and closed 872 in Q1 2023.
  • Walleye Capital's portfolio value rose 22% quarter-over-quarter to $6.67B.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.